A team of researchers from five Swedish universities have made a remarkable breakthrough in the treatment of cancer, with an equally innovative source of funding.
Led by Karolinska Institutet and the Science for Life Laboratory in Stockholm, the team has made inhibitors that kill cancer cells but not normal cells.
“We are first to show this new way of targeting cancer and this is likely going to be the major path for drug development in the future,” said Thomas Helleday, holder of the Söderberg Professorship at Karolinska Institutet, who heads the study.
Until now, most modern anti-cancer drugs have been tailored to target the genetic makeup of the cancer – a so-called personalized treatment. Sometimes this can have a long-lasting effect, but more often than not the cancers mutate to become resistant. What the team has managed to do is to target an enzyme that is required for all cancer cells for survival, but that normal cells do not need.
Helleday explained that the treatment – which comes in the form of a pill – can kill any cancer and does not have any severe side effects.
“Some say our finding sounds too good to be true, and I understand their gut feeling after seeing so many promising cancer treatments fail,” he said. “My research group has made paradigm shifts before and to those skeptics I say: just sit back and enjoy the revolution!”
What’s also revolutionary is the way the research is financed, through “open innovation” and “crowd sourcing”.
“I started a public foundation that owns all intellectual property and the idea is that we manufacture large amounts of the drug and provide it for free to the worldwide academic community, so they can design their own clinical trials and run them”, Helleday said.
“Also, as there is a public foundation behind the drug, it will not be used to enrich a few individuals, but be used for further work on new medicines.”
A lot of work remains to be done before it is time for clinical trials, which are still a year or two away, Helleday said.
Being based in Stockholm brings many advantages, including a number of highly trained drug developers looking for new challenges, he said.
“A major point is that Swedish Universities do not claim or take control on intellectual property, allowing us to donate it to a public foundation,” Helleday said.
“Another advantage is the collaborative nature of Swedes. We collaborated with five different universities to progress the project, which would have been difficult elsewhere.”
Their concept is presented in two articles in science journal Nature, with the aim of spreading the word to as many as possible in the research community.
“It has generated interest from academics across the world, to try the new concept on the cancer indication they have specialized in,” Helleday said.
The team has also sent out the compound to hundreds of scientists across the globe in an effort to increase the speed of innovation and to reach the goal of curing cancer more quickly. By freely sending out compounds, they have increased competition.
“Hundreds of scientists are advancing more quickly than one and we increase the chances of overall success,” Helleday said.
The Latest on: Cancer breakthrough
[google_news title=”” keyword=”Cancer breakthrough” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer breakthrough
- Breakthrough urine test could help men avoid unnecessary prostate biopsieson April 26, 2024 at 9:35 pm
A new urine test for prostate cancer detection is showing promise. The current standard test, the Prostate Specific Antigen, PSA, isn't very accurate at distinguishing between aggressive and ...
- BBC Radio 2 presenter who battled aggressive cancer 'in tears' over 'game-changing' breakthroughon April 26, 2024 at 7:07 am
It works by telling the body to hunt down cancer cells and prevent the deadly disease from coming back. A stage 2 trial of the jab, involving pharma firms Moderna and MSD, found it dramatically ...
- Exxon is working on tech to remove CO2 from atmosphere but a breakthrough is needed to slash costson April 25, 2024 at 5:00 pm
Regardless of who achieves a breakthrough, Exxon will have a major role to play in the market, he said. "Once we have a technology that gets to the right cost level, you're going to need global ...
- Cancer breakthrough as scientists develop super vaccine that could provide miracle cureon April 25, 2024 at 4:01 pm
Harnessing the same technology used to defeat the Covid pandemic, the mRNA jab is custom-built in a matter of weeks and given after surgery to stop the disease returning. Experts hailed it as the ...
- Lab-made miniorgans take scientists a step closer to curing canceron April 25, 2024 at 8:34 am
In the fight to cure cancer, scientists need better models. And they might just get them — human-derived organoids — thanks to light.
- Mini-colons advance colorectal cancer researchon April 24, 2024 at 8:00 am
In a breakthrough for cancer research, scientists at EPFL have created lab-grown mini-colons that can accurately mimic the development of colorectal tumors, offering a powerful new tool for studying ...
- Scientists accidentally discover new organ in major breakthrough while researching canceron April 23, 2024 at 4:30 am
The team of experts were researching prostate cancer when they discovered the new organ in the human body. Upon further investigation of 100 patients it was discovered near the nose ...
- Cancer Breakthrough Found to Boost Immune Cells Without Harmful Side-Effects By Directing Protein Cytokineson April 21, 2024 at 7:00 am
A new way to safely boost immune cells to fight cancer—avoiding harmful side-effects such as hair loss—has been developed.
- Blood cancer breakthrough could lead to 'new era' of treatment, say leading scientistson April 18, 2024 at 9:07 am
A drug breakthrough could usher in a "new era" for how an aggressive form of blood cancer is treated, scientists have said. Described by researchers as a "largely incurable disease", acute myeloid ...
- New breakthrough treatment available for nonmelanoma skin canceron April 17, 2024 at 5:57 pm
A breakthrough treatment for nonmelanoma skin cancer now available in Western Washington has over a 99 percent cure rate.
via Bing News